Biologic targeting in the treatment of inflammatory bowel diseases [Retraction]
Bosani M, Ardizzone S, Porro GB. Biologics: Targets and Therapy. 2009;3:77–97.This paper has been retracted after we were made aware that it contains a large amount of reused, and uncited material that was not placed within quotation marks.The following statement has been supplied by Dr S...
Enregistré dans:
Auteurs principaux: | Bosani M, Ardizzone S, Porro GB |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Dove Medical Press
2014
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/1483e279d73b4d2dbeb521ac0c4d794a |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Biologic targeting in the treatment of inflammatory bowel diseases
par: Matteo Bosani, et autres
Publié: (2009) -
Adalimumab for the treatment of Crohn’s disease
par: Andrea Cassinotti, et autres
Publié: (2008) -
Therapeutic Oligonucleotides for Patients with Inflammatory Bowel Diseases
par: Marafini I, et autres
Publié: (2020) -
Editorial: Game Changers in Inflammatory Bowel Diseases
par: Anita Bálint, et autres
Publié: (2021) -
Biosimilars to Antitumor Necrosis Factor Agents in Inflammatory Bowel Disease
par: Al Sulais E, et autres
Publié: (2020)